208 related articles for article (PubMed ID: 36848730)
1. In silico prediction of Antifungal compounds from Natural sources towards Lanosterol 14-alpha demethylase (CYP51) using Molecular docking and Molecular dynamic simulation.
Sama-Ae I; Pattaranggoon NC; Tedasen A
J Mol Graph Model; 2023 Jun; 121():108435. PubMed ID: 36848730
[TBL] [Abstract][Full Text] [Related]
2.
Singh G
Curr Drug Discov Technol; 2022; 19(6):e150622206033. PubMed ID: 35708080
[TBL] [Abstract][Full Text] [Related]
3. Antifungal activity of amino-alcohols based cationic surfactants and in silico, homology modeling, docking and molecular dynamics studies against lanosterol 14-α-demethylase enzyme.
Hafidi Z; El Achouri M; O Sousa FF; Pérez L
J Biomol Struct Dyn; 2022 Oct; 40(17):7762-7778. PubMed ID: 33754947
[TBL] [Abstract][Full Text] [Related]
4. Oxidation of Isodrimeninol with PCC Yields Drimane Derivatives with Activity against
Marin V; Iturra A; Opazo A; Schmidt B; Heydenreich M; Ortiz L; Jiménez VA; Paz C
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32722158
[No Abstract] [Full Text] [Related]
5. In silico and in vitro screening to identify structurally diverse non-azole CYP51 inhibitors as potent antifungal agent.
Singh A; Paliwal SK; Sharma M; Mittal A; Sharma S; Sharma JP
J Mol Graph Model; 2016 Jan; 63():1-7. PubMed ID: 26579619
[TBL] [Abstract][Full Text] [Related]
6.
Khichi A; Jakhar R; Dahiya S; Arya J; Dangi M; Chhillar AK
J Biomol Struct Dyn; 2024 Jun; 42(9):4553-4566. PubMed ID: 37293950
[TBL] [Abstract][Full Text] [Related]
7. Structural analyses of
Hargrove TY; Friggeri L; Wawrzak Z; Qi A; Hoekstra WJ; Schotzinger RJ; York JD; Guengerich FP; Lepesheva GI
J Biol Chem; 2017 Apr; 292(16):6728-6743. PubMed ID: 28258218
[TBL] [Abstract][Full Text] [Related]
8. Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
Sagatova AA; Keniya MV; Tyndall JDA; Monk BC
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263059
[TBL] [Abstract][Full Text] [Related]
9. Prediction of novel and potent inhibitors of lanosterol 14-α demethylase.
Waseem M; Thakur JK; Subbarao N
J Biomol Struct Dyn; 2023; 41(12):5744-5756. PubMed ID: 35815531
[TBL] [Abstract][Full Text] [Related]
10. Phytochemical profiling of
Siswina T; Miranti Rustama M; Sumiarsa D; Kurnia D
F1000Res; 2022; 11():1115. PubMed ID: 37151610
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis and Antifungal Activity Evaluation of New Thiazolin-4-ones as Potential Lanosterol 14α-Demethylase Inhibitors.
Stana A; Vodnar DC; Tamaian R; Pîrnău A; Vlase L; Ionuț I; Oniga O; Tiperciuc B
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106743
[TBL] [Abstract][Full Text] [Related]
12. Homology model, molecular dynamics simulation and novel pyrazole analogs design of Candida albicans CYP450 lanosterol 14 α-demethylase, a target enzyme for antifungal therapy.
Jacob K S; Ganguly S; Kumar P; Poddar R; Kumar A
J Biomol Struct Dyn; 2017 May; 35(7):1446-1463. PubMed ID: 27142238
[TBL] [Abstract][Full Text] [Related]
13. Identification of 1, 2, 4-Triazine and Its Derivatives Against Lanosterol 14-Demethylase (CYP51) Property of
Verma AK; Majid A; Hossain MS; Ahmed SF; Ashid M; Bhojiya AA; Upadhyay SK; Vishvakarma NK; Alam M
Front Med Technol; 2022; 4():845322. PubMed ID: 35419560
[TBL] [Abstract][Full Text] [Related]
14. Coumarin Antifungal Lead Compounds from Millettia thonningii and Their Predicted Mechanism of Action.
Ayine-Tora DM; Kingsford-Adaboh R; Asomaning WA; Harrison JJ; Mills-Robertson FC; Bukari Y; Sakyi PO; Kaminta S; Reynisson J
Molecules; 2016 Oct; 21(10):. PubMed ID: 27754464
[TBL] [Abstract][Full Text] [Related]
15. Molecular Modeling Studies of Halogenated Imidazoles against 14α- Demethylase from Candida Albicans for Treating Fungal Infections.
Rani N; Kumar P; Singh R
Infect Disord Drug Targets; 2020; 20(2):208-222. PubMed ID: 30499421
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antimicrobial, SAR, PASS, molecular docking, molecular dynamics and pharmacokinetics studies of 5'-
Munia NS; Hosen MA; Azzam KMA; Al-Ghorbani M; Baashen M; Hossain MK; Ali F; Mahmud S; Shimu MSS; Almalki FA; Hadda TB; Laaroussi H; Naimi S; Kawsar SMA
Nucleosides Nucleotides Nucleic Acids; 2022; 41(10):1036-1083. PubMed ID: 35797068
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Anti-Fungal Potency and In silico Studies of Novel Steroidal 1,4-Dihydropyridines.
Khan A; Iqbal A; Ahmedi S; Manzoor N; Siddiqui T
Chem Biodivers; 2023 May; 20(5):e202300096. PubMed ID: 37042439
[TBL] [Abstract][Full Text] [Related]
18. Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14α-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity.
Hargrove TY; Garvey EP; Hoekstra WJ; Yates CM; Wawrzak Z; Rachakonda G; Villalta F; Lepesheva GI
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461309
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of benzoheterocycle analogues as potent antifungal agents targeting CYP51.
Zhao S; Wei P; Wu M; Zhang X; Zhao L; Jiang X; Hao C; Su X; Zhao D; Cheng M
Bioorg Med Chem; 2018 Jul; 26(12):3242-3253. PubMed ID: 29748145
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in antifungal drug development targeting lanosterol 14α-demethylase (CYP51): A comprehensive review with structural and molecular insights.
Singh A; Singh K; Sharma A; Kaur K; Chadha R; Bedi PMS
Chem Biol Drug Des; 2023 Sep; 102(3):606-639. PubMed ID: 37220949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
